These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16235241)

  • 1. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
    Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
    Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
    Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
    Chu LW; Troncoso P; Johnston DA; Liang JC
    Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetics of prostate cancer.
    Nupponen NN; Visakorpi T
    Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects.
    Ribeiro FR; Jerónimo C; Henrique R; Fonseca D; Oliveira J; Lothe RA; Teixeira MR
    Clin Cancer Res; 2006 Jul; 12(13):3961-70. PubMed ID: 16818693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
    Jiang JK; Chen YJ; Lin CH; Yu IT; Lin JK
    Genes Chromosomes Cancer; 2005 May; 43(1):25-36. PubMed ID: 15723340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of prostate cancer.
    Visakorpi T
    Ann Chir Gynaecol; 1999; 88(1):11-6. PubMed ID: 10230676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes.
    Diep CB; Kleivi K; Ribeiro FR; Teixeira MR; Lindgjaerde OC; Lothe RA
    Genes Chromosomes Cancer; 2006 Jan; 45(1):31-41. PubMed ID: 16145679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality.
    Erbersdobler A; Graefen M; Wullbrand A; Hammerer P; Henke RP
    Prostate Cancer Prostatic Dis; 1999 Jul; 2(4):204-210. PubMed ID: 12496779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization.
    Homayounfar K; Gunawan B; Cameron S; Haller F; Baumhoer D; Uecker S; Sander B; Ramadori G; Lorf T; Füzesi L
    Hum Pathol; 2009 Jun; 40(6):834-42. PubMed ID: 19200581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential chromosome allelic imbalance in the progression of human prostate cancer.
    Latil A; Fournier G; Cussenot O; Lidereau R
    J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
    Alers JC; Krijtenburg PJ; Vis AN; Hoedemaeker RF; Wildhagen MF; Hop WC; van Der Kwast TT; Schröder FH; Tanke HJ; van Dekken H
    Am J Pathol; 2001 Feb; 158(2):399-406. PubMed ID: 11159178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genetic markers for prostatic cancer progression.
    Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
    Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
    Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.